DFTX

Conviction 100HealthcareScan · Thu, Jun 25, 2026

DFTX$44.76+6.23%

ResistanceSupportVol 14

Vol MA14 5.25M

Mar 26Apr 14May 1May 19Jun 8Jun 25

WSB mentions · 24h changelatest -61.54%· 5 mentions

Mar 26Apr 14May 1May 19Jun 8Jun 25

Definium Therapeutics, Inc.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.definiumtx.com ↗

Price44.76

Change+6.23%

Gap+0.66%

Rel volume3.11×

Avg volume4.4M

Avg $ vol145.06M

SMA 2027.05

SMA 5024.06

SMA 200—

Price vs 50+86.00%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 33.35

RSI (14)88

MACD hist2.18

MACD crossbull · 9d

Stoch %K / %D91 / 88

ADX (14)33

+DI / −DI51 / 6

RSI divergenceBearish

MACD divergenceBearish

ATR %+6.84%

ADR %7.35%

52w high44.76

52w low15.05

From 52w high+0.00%

Above 52w low+197.38%

New 52w highYes

SqueezeOff

Bollinger width98.57%

%B1.16

Donchian pos91.13%

Donchian high47.00

Donchian low21.69

AVWAP (52w high)44.39

vs AVWAP high+0.82%

AVWAP (52w low)24.39

vs AVWAP low+83.46%

OBV trendUp

Chaikin MF (20)0.00

Today vs 20d3.11×

Avg vol (14d)5.25M

Avg vol (20d)4.4M

Avg $ vol (20d)145.06M

Market cap4.88B

RS 3m (vs SPY)+124.56%

RS 6m (vs SPY)—

RS line new highYes

Trend template—

Technical rank98.7

1 week+83.20%

1 month+95.61%

3 months+142.31%

6 months—

1 year—

YTD+190.99%

P/E-26.56

P/B17.51

P/S—

P/FCF—

EPS-2.06

Div yield—

ROE-65.91%

ROA-45.80%

Debt/Eq0.15

Current4.69

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-69.12%

Price target54.50

Target upside21.77%

Analyst ratingBuy

Institutional74.45%

Ent. value4.66B

Revenue—

Net income-77.1M

Gross profit—

Free cash flow—

IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS

ExchangeNasdaq

Shares out109.07M

Employees106

ListedTue, Mar 3, 2020

Free float90.87M

Float %92.3%

Short interest9.43M

Days to cover5.2d

Short volume31.8%

Squeeze score61 / 100

Next earningsThu, Jul 30, 2026 (35d)

EPS forecast−$0.55 · 5 est

Last EPS vs est−$0.71 vs −$0.47

Last surprise-51.1% miss

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank98.7 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance25.20

Support20.51

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DFTX

All disclosures →

No recent disclosed trades by Congress in DFTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DFTX · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Barrow Robert Chief Executive Officer · Common Shares · 2026-06-22	Grant	375K	—	2026-06-22	2026-06-22
Karlin Daniel Chief Medical Officer · Common Shares · 2026-06-22	Grant	100K	—	2026-06-22	2026-06-22
Sullivan Mark Chief Legal Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22
Roberts Brandi Chief Financial Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22
Wiley Matthew T. Chief Commercial Officer · Common Shares · 2026-06-22	Grant	62.5K	—	2026-06-22	2026-06-22

SEC filings

EDGAR filings in DFTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.